ElaineM.(Kozlowski)HylekMDMPH

Professor of Medicine, Boston University

Dr. Hylek is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
801 Massachusetts Ave
Crosstown 6C
Boston, MA 02118
Phone+1 617-414-5951

Fax+1 617-414-9201

Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2013-2016
Boston Magazine Castle Connolly, 2011-2013

PubMed

471 citations
Thrombosis A Major Contributor to Global Disease Burden
Gary E. Raskob, Pantep Angchaisuksiri, Alicia N. Blanco, Harry R. Büller, Alexander Gallus
Arteriosclerosis, Thrombosis, and Vascular Biology. 2014-11-01
222 citations
2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.
Hugh Calkins, Gerhard Hindricks, Riccardo Cappato, Young-Hoon Kim, Eduardo B Saad
Europace. 2018-01-01
71 citations
Risks and Benefits of Anticoagulation in Atrial Fibrillation Insights From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry
Michael W. Cullen, Sunghee Kim, Jonathan P. Piccini, Jack Ansell, G Fonarow
Circulation. Cardiovascular Quality and Outcomes. 2013-07-01

Journal Articles

Treatment Persistence in Atrial Fibrillation: The Next Major Hurdle
Elaine (Kozlowski) Hylek, MD, Thrombosis and Haemostasis
Original Investigation Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients with Atrial Fibrillation: An ARISTOTLE Substudy
John H Alexander, Elaine M Hylek, ScienceDirect
Choosing a Particular Oral Anticoagulant and Dose for Stroke Prevention in Individual Patients with Non-Valvular Atrial Fibrillation: Part 1
Jonathan L Halperin, Elaine M Hylek, Michael D Ezekowitz, James Aisenberg, European Heart Journal

Lectures

Unanswered Questions on NOAC in AF Where Do We Go From Here?
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019

Catheter-Directed Fibrinolysis Safe in Intermediate-High-Risk Pulmonary EmbolismDecember 16th, 2022
Hints of Benefit with Catheter-Directed Thrombolysis in Intermediate/High-Risk PEOctober 19th, 2022
Catheter-Directed Thrombolysis Promising for Intermediate-Risk Pulmonary EmbolismOctober 19th, 2022
Join now to see all